trial · primary record
HRS-6209 + Letrozole
Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1050 |
| Primary completion | 2031-09-30 |
| Primary endpoint | Progression-Free Survival (PFS) Determined by Blinded Independent Central Review (BICR) |
| Registry ID | NCT07894328 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:16.445Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07894328
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.